Does cortisone (hydrocortisone) cross the blood‑brain barrier?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Cortisone (Hydrocortisone) Cross the Blood-Brain Barrier?

Yes, hydrocortisone crosses the blood-brain barrier, but it does so slowly and to a limited extent compared to other corticosteroids like dexamethasone. 1, 2

Blood-Brain Barrier Penetration Characteristics

Hydrocortisone (Cortisol) Penetration

  • Hydrocortisone demonstrates poor penetration across the blood-brain barrier, with an extraction rate of only 1.4 ± 0.3% after a single pass through brain tissue in experimental models 1

  • The low penetration is directly related to hydrocortisone's high number of hydrogen bond-forming functional groups (which increases water solubility) and its relatively low lipid partition coefficient 1

  • Despite poor initial extraction, hydrocortisone is detectable in cerebrospinal fluid after oral administration, with levels of 14 ± 2 ng/ml at 2 hours, 29 ± 9 ng/ml at 4 hours, and 17 ± 7 ng/ml at 6 hours following a 40 mg oral dose of prednisone (which converts to prednisolone, similar to hydrocortisone) 3

Mechanism of Transport

  • Steroid hormones, including hydrocortisone, cross the blood-brain barrier primarily through transmembrane diffusion, a nonsaturable process that results in brain levels reflecting blood levels 2

  • Hydrocortisone is structurally identical to native cortisol and binds to both mineralocorticoid and glucocorticoid receptors, which are present in high density in the hippocampus 4, 5

  • The hormone available for blood-brain barrier transport is not restricted to the free (dialyzable) fraction but includes the larger albumin-bound fraction, though globulin-bound hormone does not appear to be transported significantly 1

Clinical Implications for Neurologic Conditions

When Blood-Brain Barrier Penetration Matters

  • For patients with neurologic symptoms (such as in CAR T-cell therapy-related neurotoxicity), dexamethasone is preferred over hydrocortisone due to its superior blood-brain barrier penetration 4

  • Dexamethasone has an extraction rate of approximately 83-85% compared to hydrocortisone's 1.4%, making it roughly 60 times more effective at penetrating the central nervous system 1

Safety Profile Differences

  • Hydrocortisone has not shown adverse effects on memory or neurodevelopmental outcomes in neonatal studies, unlike dexamethasone which causes hippocampal neuronal degeneration in animal models 4, 6

  • This differential safety profile exists despite both drugs acting through glucocorticoid receptors, likely because hydrocortisone also binds mineralocorticoid receptors and is used at lower equivalent glucocorticoid doses 4, 5

Common Pitfalls to Avoid

  • Do not assume hydrocortisone provides adequate CNS coverage for conditions requiring direct brain tissue corticosteroid effects—switch to dexamethasone when neurologic symptoms are present 4

  • Do not use dexamethasone alone in primary adrenal insufficiency expecting it to replace hydrocortisone's mineralocorticoid activity, as dexamethasone completely lacks this property despite better CNS penetration 5

  • Avoid combining hydrocortisone with dexamethasone in most clinical scenarios, as this simply adds to total glucocorticoid burden without additional therapeutic benefit, except in primary adrenal insufficiency where mineralocorticoid replacement is essential 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Glucocorticoid Therapy with Dexamethasone and Hydrocortisone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Corticosteroid-Induced Memory Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.